JS–114
Experimental drug for cancer treatment
JS–114 is an experimental drug currently under investigation for its potential use in cancer treatment. It is classified as a small molecule inhibitor and is designed to target specific pathways involved in the proliferation and survival of cancer cells.
Mechanism of Action[edit | edit source]
JS–114 functions by inhibiting the activity of certain protein kinases that are essential for the growth and survival of cancer cells. By blocking these kinases, JS–114 can induce apoptosis (programmed cell death) in cancer cells and inhibit their ability to proliferate.
Clinical Trials[edit | edit source]
As of now, JS–114 is undergoing clinical trials to evaluate its safety and efficacy. These trials are conducted in multiple phases, starting with Phase I clinical trials to assess the drug's safety profile, followed by Phase II clinical trials to evaluate its efficacy, and finally Phase III clinical trials to compare it against standard treatments.
Potential Applications[edit | edit source]
JS–114 is being studied for its potential use in treating various types of cancer, including breast cancer, lung cancer, and colorectal cancer. Researchers are particularly interested in its ability to target cancer cells with specific genetic mutations that make them resistant to conventional therapies.
Side Effects[edit | edit source]
Like many cancer treatments, JS–114 may have side effects. Common side effects observed in early trials include nausea, fatigue, and diarrhea. More serious side effects are being closely monitored as the drug progresses through clinical trials.
Future Directions[edit | edit source]
The future of JS–114 will depend on the outcomes of ongoing clinical trials. If proven effective, it could become a valuable addition to the arsenal of targeted cancer therapies. Researchers are also exploring the possibility of combining JS–114 with other treatments to enhance its efficacy.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
